RELX's Quality and Safety Lab in Shenzhen Accredited by CNAS

Aug.03.2022
RELX's Quality and Safety Lab in Shenzhen Accredited by CNAS
RELX's Shenzhen quality safety lab gains CNAS certification, ensuring global recognition of its testing reports.

On August 2nd, a Blue Whale Finance journalist learned from RELX Yueke (Fogcore Technology) that its quality and safety laboratory in Shenzhen has received recognition from CNAS (China National Accreditation Board for Laboratories).


According to the information provided, CNAS (China National Accreditation Service For Conformity Assessment) is the English abbreviation for the China National Accreditation Committee for Conformity Assessment. Laboratories accredited by CNAS can issue testing reports that are recognized by more than 100 countries worldwide.


As per reports, the Yooz Quality and Safety Laboratory, mentioned earlier, was established in 2021 and covers an area of 450 square meters, serving as a key support component of the Yooz quality system. The laboratory focuses on testing the physical and electrical properties of products and is the second laboratory accredited by CNAS (China National Accreditation Service) within the company, Fogcore Technology. Yooz's first accredited laboratory, dedicated to testing e-liquid, was certified in August 2020, making it the first e-cigarette brand company to receive CNAS accreditation.


In fact, in daily use, electronic cigarettes in the hands of consumers are inevitably subjected to shocks and impacts, as well as challenges from wind, heat, and cold, with their durability and safety directly affecting the user experience. Therefore, in order to pursue top-quality products, YOOZ, in terms of quality and safety testing, has set up multiple tests including friction, drop, and high temperature in its quality safety laboratory. "At present, we have the ability to carry out testing in accordance with national standards," said Yang Yong, head of the YOOZ Quality Compliance Center. "In addition, we have also improved our testing standards by starting from many invisible details.


For example, YUEKE has an exclusively patented system for assessing suction noise, which helps quality engineers monitor the decibel levels of the sounds emitted during product use in real-time to reduce noise levels to the greatest extent possible and achieve "no disturbance" in terms of hearing. Meanwhile, the company also offers optional testing for cosmetics endurance. Engineers apply skincare products to atomizer rods and observe whether the product's appearance changes in high-temperature, high-humidity environments. This process can test the anti-corrosion abilities of different atomizer rods and identify the most durable products for users.


To address the widely-concerned issue of oil leakage, engineers conducted laboratory experiments simulating high-altitude pressures exceeding 3000 meters above sea level, testing atomized bombs. The tested products greatly mitigate oil leakage caused by changes in pressure.


In March of this year, national standards for electronic cigarettes as well as regulations for their management were issued, marking a move towards the legalization and standardization of the electronic cigarette industry. Yang Yong stated that Yooz will take on its quality responsibilities and strive for the highest quality, creating products that have a pure flavor.


It has been reported that YUEKE, since its inception, has invested a total of 800 million yuan in research and development, creating a matrix of eight large laboratories. In addition to the quality and safety laboratory, there are also innovation laboratories, chemical laboratories, life science laboratories, aerosol laboratories, atomization innovation laboratories, new material laboratories, sensory analysis laboratories, and after-sales testing centers. The quality system covers the entire user experience process.


According to Yang Yong, chemical laboratories can analyze the chemical components of aerosols and sprays, while life science laboratories are responsible for safety testing at the cellular and animal levels. By conducting multiple layers of testing, we ensure that the quality and safety of our products are implemented in every detail.


According to reports, the Yueke Chemical Laboratory tests 19 categories of 140 substances and 12 categories of 102 substances for aerosols. The Life Science Laboratory is capable of conducting six tests, such as cell toxicity, to further confirm product safety.


According to reports, Fogtech has recently been awarded the "License for Tobacco Monopoly Production Enterprise (Electronic Cigarette Product Production Enterprise)". Currently, the company is intensively developing new products that meet national standards, and some products have passed technical evaluations. In its statement, Fogtech said it will continue to aim for a perfect user experience and provide high-quality and reassuring products.


This article contains excerpts or reprints from third-party sources, whose copyright belongs to the original media and author. If there is any infringement, please contact us to delete it. Any organization or individual wishing to reprint must contact the author and refrain from reprinting directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
China’s Shanghai Tobacco Group Launches CNY 10.98 Million (Approximately US$1.53 Million) Procurement for Heated Tobacco Production Utility Equipment
China’s Shanghai Tobacco Group Launches CNY 10.98 Million (Approximately US$1.53 Million) Procurement for Heated Tobacco Production Utility Equipment
Shanghai Tobacco Group Co., Ltd., a tobacco manufacturing company under China National Tobacco Corporation (CNTC), has launched a public tender for heated tobacco products (HTPs) production utility equipment at its Shanghai Cigarette Factory. The project is valued at CNY 10.98 million and covers six combined air-conditioning units, electrical cabinets and control systems for production facilities. The procurement includes equipment design, supply, installation, commissioning and related training services.
Aug.07
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
The UK’s Vaping Products Duty (VPD), scheduled to take effect in October 2026, is prompting retailers to assess how different vape categories may be affected. UK retailer Vape HQ has estimated potential price changes under the new volume-based tax system, showing that 100ml shortfill e-liquids could see prices rise from around £12.99 to £39.39, a 203% increase, while 2ml prefilled pod vape kits could rise from £5.99 to £6.52, an increase of about 9%. The estimates highlight how a volume-based tax structure creates uneven cost impacts across product categories.
Aug.19
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
U.S. Senator Ron Wyden, the Democratic ranking member of the Senate Finance Committee, has launched an investigation into flavored vape policy changes and requested records from the Department of Health and Human Services (HHS), Reynolds American and Botanic Tonics. The investigation focuses on a timeline involving Reynolds American’s $5 million donation to MAGA Inc. in April 2026 and subsequent vape policy developments. Wyden said the review aims to examine potential links between political donations, corporate communications and government decisions. The investigation does not represent a finding of wrongdoing.
Innovation
Aug.07 by 2Firsts Perspectives
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10